were elevated. The presence of hyporeninemic hypoaldosteronism confirmed diagnosis of cerebral salt wasting and ruled out inappropriate secretion of antidiuretic hormone. Treatment included substitution of thyroxine, hydrocortisone, and fludrocortisone and high doses of intravenous NaCl (up to 60 mmol/kg per day). With clinical stabilization, oral substitution with microencapsulated NaCl was started (maximal daily dose ‫ס‬ 16 mmol/kg, equivalent to 0.85 g/kg) and was continued for 2.5 months before fatal tumor progression demanded intravenous substitution again (Fig. 1) .
For retarded release, drug coating (microencapsulation) is established in pharmaceutical technology (e.g., for acetylsalicylic acid, dipyridamole, or theophylline) but has not yet been described for NaCl (4) .
For the microencapsulation of NaCl, crystalline NaCl (particle size ‫ס‬ 100-700 m) was coated with ammonium methacrylate copolymer type B (Eudragit™ RS 12.5; Röhm Pharma, Weiterstadt, Germany) (5). Film-forming copolymer (500 g) was dissolved in 4000 g of a mixture containing 2-propanol and acetone, 3 : 2 (vol/vol). The coating process was performed in a Kugelcoater HKC-5-TJ (Hüttlin, Steinen, Germany) equipped with a turbojet device and bottom-spray nozzles. NaCl (2870 g) was preheated in the Kugelcoater with an inlet air temperature of 40°C. The coating process was started at 35°C, with an average spray rate of 12 g/minute. During the spraying process, the temperature was kept below 30°C to prevent sticking. The atomizing air pressure was set to 0.1 megapascal (MPa); the microclimate pressure around each nozzle was 0.05 MPa. The air volume was 250 m 3 / hour in the beginning and decreased to 180 m 3 /hour. The product was vacuumdried. The dissolution of coated granules was monitored in purified water by conductometric determination of NaCl concentration; 50% of the encapsulated NaCl was released after 60 minutes.
The flavorless microencapsulated granules can be mixed easily with yogurt, pudding, or mashed baby food because the adverse effects of NaCl solution, such as nausea and vomiting, can be overcome by the preparation described.
In conclusion, coating of NaCl appears to be a cheap, simple, and effective way to administer large doses of salt orally to pediatric patients.
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